Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last? [Yahoo! Finance]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: Yahoo! Finance
Adaptive Biotechnologies (ADPT) shares ended the last trading session 5.8% higher at $13.17. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 19.9% loss over the past four weeks. Adaptive Biotechnologies' stock price gain can be attributed to the positive investor mindset regarding the potential of its pipeline. The company is advancing a portfolio focused on immune-profiling diagnostics and immune-driven drug discovery. Its lead commercial product, clonoSEQ, is used to monitor minimal residual disease in hematologic cancers such as multiple myeloma and leukemia, and the company continues to expand its clinical adoption and regulatory indications. Additionally, the company's Immune Medicine platform aims to discover T-cell receptor-based therapeutics targeting infectious diseases, cancer and autoimmune conditions. The company is also progressing research programs to identify disease-specifi
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Adaptive Biotechnologies CEO Flags MRD Momentum, Lifts 2025 Volume Outlook to 30%+ at TD Cowen Conf. [Yahoo! Finance]Yahoo! Finance
- Why are Analysts Optimistic About Adaptive Biotechnologies (ADPT)? [Yahoo! Finance]Yahoo! Finance
- TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT) [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies (NASDAQ:ADPT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ADPT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall MarketBeat
ADPT
Earnings
- 2/5/26 - Beat
ADPT
Sec Filings
- 3/18/26 - Form 4
- 3/16/26 - Form 144
- 3/16/26 - Form 144
- ADPT's page on the SEC website